MHRA: Labelling of medicines: Reminder – update to labelling to comply with Article 54(a), 54(e) and 56(a)

The legislation provided a transitional period for the labelling of medicines which were the subject of a granted marketing authorisation at the time the regulations came into force on 30 October 2005. This transitional period ends on 30 October 2010 by which time the necessary applications must have been approved to bring the marketing authorisations into compliance.